Amanote Research
Register
Sign In
NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk
Hepatology
- United States
doi 10.1002/hep.29052
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Hepatology
Date
April 24, 2017
Authors
Amedeo Lonardo
Fabio Nascimbeni
Stefano Ballestri
Publisher
Wiley
Related search
The Role of NAFLD in Cardiometabolic Disease: An Update
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Seroprevalance and Co-Infection of Hepatotropic Viruses in Acute Viral Hepatitis Cases
International Journal of Current Microbiology and Applied Sciences
Identification of Hepatotropic Viruses From Plasma Using Deep Sequencing: A Next Generation Diagnostic Tool
PLoS ONE
Multidisciplinary
Monitoring Cardiometabolic Risk in Schizophrenia
British Journal of Psychiatry
Medicine
Psychiatry
Mental Health
Cardiometabolic Risk: A Framingham Perspective
International Journal of Obesity
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Adolescent Obesity, Bone Mass, and Cardiometabolic Risk Factors
Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Childhood Obesity, Bone Development, and Cardiometabolic Risk Factors
Molecular and Cellular Endocrinology
Biochemistry
Endocrinology
Molecular Biology
Synergistic Effects of Serum Uric Acid and Cardiometabolic Risk Factors on Early Stage Atherosclerosis: The Cardiometabolic Risk in Chinese Study
PLoS ONE
Multidisciplinary
Urbanisation, Nutrition Transition and Cardiometabolic Risk: The Benin Study
British Journal of Nutrition
Medicine
Nutrition
Dietetics